At the end of last month, the WHO announced the implementation of a new financing model for their Prequalification programme, to take effect in January 2017. The detailed scheme and other questions and answers that any manufacturers may have are also available on the WHO website.
A third mifepristone product, manufactured by Acme Formulation in India, has received a positive score for procurement by the Expert Review Panel (ERP).
The United Nations Population Fund (UNFPA) has issued its 9th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP).
The World Health Organisation Prequalification of Medicines Programme (WHO PQP) has published a 7th Invitation to an Expression of Interest (EOI) for Reproductive Health (RH) medicines.
Collaborative registration is a useful procedure for manufacturers, which serves to facilitate and accelerate national registration of products that have been prequalified by WHO PQP.
Newly posted WHO PQ publication provides useful information for any manufacturer that is hesitating to get their product prequalified by the WHO.